Newborn screening is essential to improve diagnosis and outcomes

Maintaining the voice of rare diseases in a new, virtual world: Insights from the European Conference on Rare Diseases (ECRD) 2020

Newborn screening is essential to improve diagnosis and outcomes

Alpharmaxim work closely with industry to provide education around newborn screening and can help to drive awareness of newborn screening panels. It is important to increase the number of newborn screening panels and harmonise their number and size across Europe. Newborn screening:

Allows for early diagnosis and, therefore, management of rare genetic diseases
Could have a significant impact on the burden on healthcare systems and patients/families
Could lead to a reduction in later misdiagnosis and suffering

Be prepared to truly demonstrate your commitment to the rare disease field, particularly in these uncertain times.

Talk to us about how we can transform your communications

Why Plain Language Summaries are vital in rare disease communications

Plain language summaries can translate complex science for different audiences. But what are they, and how do they improve awareness?

What can COVID-19 campaigns tell us about increasing vaccine uptake?

We examine what lessons we can take from the COVID-19 vaccine campaigns, and how behavioural science insights may help to drive vaccine uptake.

Transforming the rare disease landscape

Over the coming months, we’ll be looking at how new, tailored approaches to communications could help transform the rare disease landscape.